#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital growth hormone deficiency Vulval cancer Intracranial calcification Non-Hodgkin's lymphoma refractory Cytomegalovirus infection Alexander disease Acute myeloid leukaemia refractory Ischaemic stroke Shprintzen-Goldberg syndrome Adenocarcinoma pancreas Peritoneal mesothelioma malignant Leiomyosarcoma Glioblastoma Nasopharyngeal cancer Follicular lymphoma More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Basic Information Mantle cell lymphoma stage II – Treatment VEXAS syndrome – Life with Disease Synovial sarcoma recurrent – Treatment Usher’s syndrome – Basic Information Synovial sarcoma metastatic – Diagnostics Glycogen storage disease type V – Trials in Disease Niemann-Pick disease – Basic Information Waldenstrom’s macroglobulinaemia refractory – Life with Disease Marfan’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Solrikitug Caplacizumab RNMB2 Namilumab Raxtozinameran Napabucasin Tetracosactide Fluoroethyltyrosine F-18 VANADIUM OXIDE SULFATE Doxazosin Tenecteplase Serpina1(Human)-Aav8-1 Mps-216 ICEF15 D5-Ethyl-Beta-D-Glucuronide IMMUNOSTEM Vinorelbine Tartrate Esk-001 Damoctocog Alfa Pegol INSULIN DEGLUDEC More therapies…

    Learn about Your Condition

    Follicular lymphoma Progressive supranuclear palsy Nocturia Pyoderma Pharyngeal cancer stage I Hyperglycaemia Naevoid melanoma Thymoma Peritonitis Rheumatic disorder Chronic granulomatous disease Critical illness Acute coronary syndrome Cholangiosarcoma Glomerulonephritis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing

ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing

Griesgasse 18, Dingolfing, 84130, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Trifluridine/Tipiracil with Panitumumab or Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Panitumumab
    • Bevacizumab
    • Tipiracil Hydrochloride
    Germany

  • Study on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Extranodal marginal zone B-cell lymphoma (MALT type)
    • Splenic marginal zone lymphoma
    • Nodal marginal zone B-cell lymphoma
    Investigated Drugs:
    • Copanlisib Dihydrochloride
    • Rituximab
    Germany

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!